The Patent Finder

Terms ending in 2039

Ablynx N.V.

Every in-force patent on Ablynx N.V.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,033,636Polypeptides Antagonizing WNT Signaling in Tumor Cells
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 12,285,493Polypeptides Antagonizing WNT Signaling in Tumor Cells
In force
 · Low confidence
Boehringer Ingelheim International GmbHIn forceLow confidence
US 12,753,224Aggrecan Binding Immunoglobulins
In force
 · High confidence
Merck Patent GmbHIn forceHigh confidence
US 11,813,307Polypeptides Binding ADAMTS5, MMP13 and Aggrecan
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 12,371,496T Cell Recruiting Polypeptides Based on CD3 Reactivity
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 12,209,136ADAMTS Binding Immunoglobulins
In force
 · Medium confidence
Ablynx N.V. and SanofiIn forceMedium confidence
US 11,999,797Methods of Treating Initial Episode of TTP with Immunoglobulin Single Variable Domains
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 12,480,957Method of Screening for Anti-Drug Antibodies Against Immunoglobulin Single Variable Domain-Based Drugs
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
8 of 8 patents shown. Soonest term end first, then patent number.
6 of these are in force and held by Ablynx N.V..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited